Literature DB >> 9285911

Acute oral toxicity of microcystin-LR, a cyanobacterial hepatotoxin, in mice.

T Yoshida1, Y Makita, S Nagata, T Tsutsumi, F Yoshida, M Sekijima, S Tamura, Y Ueno.   

Abstract

Microcystin-LR (MCLR) is a hepatotoxic peptide produced by Microcystis aeruginosa, an alga found worldwide in reservoirs for drinking supply; however, acute oral toxicity of purified MCLR remains unknown. Therefore, a single dose of MCLR (more than 95% purity) ranging from 8.0 to 20.0 mg/kg body weight was orally given to female 6-week old BALB/c mice, and lethality and pathological changes were observed. Median lethal dose (LD50) of the orally given MCLR estimated by the up and down method was 10.9 mg/kg, which was 167 times higher than the i.p. LD50 value (65.4 microgram/kg by moving average method). Orally administrated toxin caused primarily hepatocellular injuries with characteristics of hemorrhage and necrosis. In situ end-labeling as well as electron microscopic observation revealed an induction of apoptotic cell death to hepatocytes. These results indicate the lethality of MCLR was much lower in oral dosage than by i.p. administration, but toxic effects are similar. In addition, apoptosis is considered one of major components in MCLR-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285911     DOI: 10.1002/1522-7189(1997)5:3<91::AID-NT1>3.0.CO;2-H

Source DB:  PubMed          Journal:  Nat Toxins        ISSN: 1056-9014


  26 in total

1.  Microcystin-LR induced liver injury in mice and in primary human hepatocytes is caused by oncotic necrosis.

Authors:  Benjamin L Woolbright; C David Williams; Hongmin Ni; Sean C Kumer; Timothy Schmitt; Bartholomew Kane; Hartmut Jaeschke
Journal:  Toxicon       Date:  2016-11-23       Impact factor: 3.033

2.  Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice.

Authors:  Min Lian; Ying Liu; Shun-Zhang Yu; Geng-Sun Qian; Shu-Guang Wan; Kenneth-R Dixon
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

3.  Subchronic Toxicity of Microcystin-LR on Young Frogs (Xenopus laevis) and Their Gut Microbiota.

Authors:  Jinjin Li; Hongzhao Sun; Chun Wang; Shangchun Li; Yunfei Cai
Journal:  Front Microbiol       Date:  2022-05-12       Impact factor: 6.064

Review 4.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

5.  Toxins produced in cyanobacterial water blooms - toxicity and risks.

Authors:  Luděk Bláha; Pavel Babica; Blahoslav Maršálek
Journal:  Interdiscip Toxicol       Date:  2009-06

6.  Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I.

Authors:  Zachary R Woydziak; A John Yucel; A Richard Chamberlin
Journal:  ChemMedChem       Date:  2020-12-10       Impact factor: 3.466

Review 7.  Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment.

Authors:  B C Hitzfeld; S J Höger; D R Dietrich
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

8.  Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog.

Authors:  Adrienne C Bautista; Caroline E Moore; Yanping Lin; Martha G Cline; Noemi Benitah; Birgit Puschner
Journal:  BMC Vet Res       Date:  2015-06-19       Impact factor: 2.741

9.  Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?

Authors:  Katerina Vareli; Walter Jaeger; Anastasia Touka; Stathis Frillingos; Evangelos Briasoulis; Ioannis Sainis
Journal:  Mar Drugs       Date:  2013-08-05       Impact factor: 5.118

Review 10.  Azaspiracid shellfish poisoning: a review on the chemistry, ecology, and toxicology with an emphasis on human health impacts.

Authors:  Michael J Twiner; Nils Rehmann; Philipp Hess; Gregory J Doucette
Journal:  Mar Drugs       Date:  2008-05-07       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.